Paper37208596
The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis.
Lampl C and 10 others. J Headache Pain, 2023. Cited by 112 papers, by iCite.
Cite this record
ConductScience Library. The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis. Papers, record 37208596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37208596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Valproic Acid | Major topic |
| Migraine Disorders | Major topic |
| Adult | |
| Humans | |
| Topiramate | |
| Gabapentin | |
| Calcitonin Gene-Related Peptide | |
| Amitriptyline | |
| Antibodies, Monoclonal |
Source PubMed
References112
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35690723 | European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update. | J Headache Pain | 2022 | https://conductscience.org/library/papers/35690723 | PubMed |
| 2 | 20813784 | Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). | Cephalalgia | 2011 | https://conductscience.org/library/papers/20813784 | PubMed |
| 3 | 29368949 | Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. | Cephalalgia | 2018 | https://conductscience.org/library/papers/29368949 | PubMed |
| 4 | 31612482 | A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults. | Headache | 2019 | https://conductscience.org/library/papers/31612482 | PubMed |
| 5 | 21070231 | Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. | Headache | 2011 | https://conductscience.org/library/papers/21070231 | PubMed |
| 6 | 20961988 | Tricyclic antidepressants and headaches: systematic review and meta-analysis. | BMJ | 2010 | https://conductscience.org/library/papers/20961988 | PubMed |
| 7 | 7872882 | Migraine prophylaxis with divalproex. | Arch Neurol | 1995 | https://conductscience.org/library/papers/7872882 | PubMed |
| 8 | 29939406 | Botulinum toxins for the prevention of migraine in adults. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29939406 | PubMed |
| 9 | 3902723 | A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache. | Headache | 1985 | https://conductscience.org/library/papers/3902723 | PubMed |
| 10 | 25127173 | Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. | Lancet Neurol | 2014 | https://conductscience.org/library/papers/25127173 | PubMed |
| 11 | 12503978 | Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. | JAMA | 2003 | https://conductscience.org/library/papers/12503978 | PubMed |
| 12 | 8902255 | Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group. | Cephalalgia | 1996 | https://conductscience.org/library/papers/8902255 | PubMed |
| 13 | 30529648 | GRADE approach to rate the certainty from a network meta-analysis: addressing incoherence. | J Clin Epidemiol | 2019 | https://conductscience.org/library/papers/30529648 | PubMed |
| 14 | 35760451 | Theory and practice of Bayesian and frequentist frameworks for network meta-analysis. | BMJ Evid Based Med | 2023 | https://conductscience.org/library/papers/35760451 | PubMed |
| 15 | 34323290 | Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients. | Headache | 2021 | https://conductscience.org/library/papers/34323290 | PubMed |
| 16 | 23406477 | Amitriptyline vs divalproate in migraine prophylaxis: a randomized controlled trial. | Acta Neurol Scand | 2013 | https://conductscience.org/library/papers/23406477 | PubMed |
| 17 | 19393844 | Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. | Clin Ther | 2009 | https://conductscience.org/library/papers/19393844 | PubMed |
| 18 | 25107879 | Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention. | Neurology | 2014 | https://conductscience.org/library/papers/25107879 | PubMed |
| 19 | 15096395 | Topiramate in migraine prevention: results of a large controlled trial. | Arch Neurol | 2004 | https://conductscience.org/library/papers/15096395 | PubMed |
| 20 | 18436948 | GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. | BMJ | 2008 | https://conductscience.org/library/papers/18436948 | PubMed |
Cited by77
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42768771 | Factors Impacting the Telephone Follow-Up Response Rate in Patients With Migraine Without Aura: A Cross-Sectional Study of 1299 Females. | Pain Res Manag | 2026 | https://conductscience.org/library/papers/42768771 | PubMed |
| 42741009 | A multidisciplinary multicentric approach to the identification of predictive biomarkers of response to erenumab - the protocol of the phase 4, European, open-label controlled trial of the BIOMIGA project. | Front Neurol | 2026 | https://conductscience.org/library/papers/42741009 | PubMed |
| 42717153 | Effectiveness of Rimegepant for the Acute Treatment of Migraine Among Participants Using Different Types of Preventive Therapy: Analyses from CONFIDENCE. | Neurol Ther | 2026 | https://conductscience.org/library/papers/42717153 | PubMed |
| 42591761 | Phenotype-guided selection of venlafaxine and topiramate for vestibular migraine: a narrative review. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42591761 | PubMed |
| 42484949 | Non-Pharmacological Treatments of Migraine: Current Evidence and Clinical Practice. | Curr Pain Headache Rep | 2026 | https://conductscience.org/library/papers/42484949 | PubMed |
| 42440212 | Safety and Effectiveness of Pain Medications for Migraine Management During Pregnancy and Lactation. | Paediatr Drugs | 2026 | https://conductscience.org/library/papers/42440212 | PubMed |
| 42356466 | Therapeutic Overlap Between Bipolar Disorder and Migraine: A Systematic Review of Pharmacological Trials. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42356466 | PubMed |
| 42327808 | Evaluating the efficacy of rimegepant as a preventive treatment for chronic and episodic migraine: a three-month longitudinal retrospective cohort study. | Front Neurol | 2026 | https://conductscience.org/library/papers/42327808 | PubMed |
| 42237015 | Cost-Utility Analysis of Calcitonin Gene-Related Peptide Monoclonal Antibodies for Patients with Episodic Migraine Headache in the USA. | Pharmacoeconomics | 2026 | https://conductscience.org/library/papers/42237015 | PubMed |
| 42163197 | Prophylactic efficacy and safety of valproate versus topiramate for migraine: a systematic review. | BMC Neurol | 2026 | https://conductscience.org/library/papers/42163197 | PubMed |
| 42113558 | Associations between psychedelic use and migraine history in Swedish twins. | J Psychopharmacol | 2026 | https://conductscience.org/library/papers/42113558 | PubMed |
| 42067810 | Real-world effectiveness of onabotulinumtoxinA as first-line treatment in chronic migraine and sequential transition to anti-CGRP monoclonal antibodies: a retrospective multicenter study. | BMC Neurol | 2026 | https://conductscience.org/library/papers/42067810 | PubMed |
| 42042754 | Comparing the Efficacy and Safety of Anti-CGRP Monoclonal Antibodies Versus Topiramate for Migraine Prophylaxis: Six-Month, Real-World, Intention-to-Treat Retrospective Evidence from the GRASP Study Group. | Neurol Int | 2026 | https://conductscience.org/library/papers/42042754 | PubMed |
| 42017407 | Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3-Month results from the TRIUMPH study. | Headache | 2026 | https://conductscience.org/library/papers/42017407 | PubMed |
| 41908273 | Efficacy of Petasites hybridus in migraine prophylaxis: the first real-world study. | Front Neurol | 2026 | https://conductscience.org/library/papers/41908273 | PubMed |
| 41893566 | OnabotulinumToxinA Reduces Pharmacological Burden in Chronic Migraine Patients: A Two-Center Prospective Cohort Study. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/41893566 | PubMed |
| 41872760 | The effect of targeted upper cervical musculoskeletal management on the frequency and burden of migraine headache in adults - a single cohort pilot study. | J Man Manip Ther | 2026 | https://conductscience.org/library/papers/41872760 | PubMed |
| 41829891 | Migraine and the Gut-Brain Axis-The Role of Microbiome-Targeted Biotics. | Nutrients | 2026 | https://conductscience.org/library/papers/41829891 | PubMed |
| 41827347 | Neurologic Symptoms and Cerebrovascular Events During Atogepant Therapy: A Case Series with Contextual Comparison with a Non-Gepant-Treated Migraine Cohort. | J Clin Med | 2026 | https://conductscience.org/library/papers/41827347 | PubMed |
| 41703442 | Diagnosis challenges and accessibility barriers to migraine management in Southeast Asia: results from the South-East Asia Local breAch on MigraiNe Treatment (SEALANT) study. | J Headache Pain | 2026 | https://conductscience.org/library/papers/41703442 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AGTR1 | 185 | PubTator's text mining | https://conductscience.org/library/genes/185 | NCBI Gene |
| CALCA | 796 | PubTator's text mining | https://conductscience.org/library/genes/796 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37208596
GET https://conductscience.org/api/papers/v1/37208596/references?page=2